Switching from treatment with BHI, IGlar, or NPH to BIAsp 30 (all ± OGLDs) was found to be cost-effective in India, Indonesia, and Saudi Arabia, both in the long and short term.
Starting BIAsp 30 in people with type 2 diabetes in the A(1)chieve study was found to be cost-effective across all country settings at 1- and 30-year time horizons, and usefully increased predicted life expectancy.
trality and percentages determined. RESULTS: The data reveal a 100% written diagnosis for all prescriptions encountered. There were more females than males (70% vs 30%). The average number of drugs per prescription was 6.0. About 61% of the diabetic patients were also diagnosed with hypertension. Biguanides (95%) were the commonest oral hypoglycaemic agent prescribed while calcium channel antagonist (60%) was the commonest antihypertensive prescribed. The average cost of medication per prescription was GHC 40.0 (Ghana cedi) -approx $20.5 (USD), were as the average total cost of drugs per patient for the entire year was GHC 235.2 (Ghana cedi) -approx $120 (USD) CONCLUSIONS: The study demonstrates that most patients attending the diabetic clinic in Ho Municipal Hospital are females. The cost of diabetic medications to patient per prescription was expectedly high, particularly due to the high number of drugs prescribed. Most diabetic patients have hypertension. The prescription of ACE-I therefore need to be improved to reduce the rate of cardiovascular complication in diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.